Status:
COMPLETED
Comparative Effectiveness of Telemedicine in Primary Care
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
19+ years
Brief Summary
Leveraging a natural experiment approach, the investigators will examine rapidly changing telemedicine and in-person models of care during and after the COVID-19 crisis to determine whether certain pa...
Detailed Description
During the COVID-19 pandemic, telemedicine has quickly emerged as the primary method of providing outpatient care in many regions with shelter-in-place and social distancing policies. It is critical t...
Eligibility Criteria
Inclusion
- patients that are attributed to primary care clinics across four health systems in the INSIGHT (Mount Sinai Health System and Weill Cornell Medicine), OneFlorida (University of Florida Health), and STAR (University of North Carolina Health) CRNs.
- Patients received two or more outpatient visits at a participating practice during a one-year period before the COVID-19 pandemic,
- Patients had one or more of five chronic illnesses (asthma, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), diabetes, hypertension) as defined by the Medicare Chronic Conditions Warehouse algorithm
Exclusion
- Patients who tested COVID-positive
- Patients from hospice and palliative care practices
- Patients from osteopathic medicine practices
- Patients from pediatric practices
- Patients that did not reside in states where the four health systems were located: the New York-Tri State Area (Connecticut, New York, and New Jersey), Florida, and North Carolina.
- Patients that moved out of state (or out of the New York-Tri State Area) or who died during the study period were also excluded.
- Patients who were not continuously enrolled over the entire study period (2019-2021).
Key Trial Info
Start Date :
March 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
33100 Patients enrolled
Trial Details
Trial ID
NCT04684836
Start Date
March 15 2021
End Date
April 1 2022
Last Update
September 19 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, New York, United States, 32610
2
Mount Sinai
New York, New York, United States, 10029
3
Weill Cornell Medicine
New York, New York, United States, 10065
4
University of North Carolina
Chapel Hill, North Carolina, United States, 27599